Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy

Published:2020-07-21 Issue:17 Volume:9 Page:6281-6295
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zhao Yanding¹²,Schaafsma Evelien¹²,Cheng Chao¹²³⁴^ORCID

Affiliation:

1. Department of Molecular and Systems Biology The Geisel School of Medicine at Dartmouth College Lebanon NH USA

2. Department of Biomedical Data Science The Geisel School of Medicine at Dartmouth College Lebanon NH USA

3. Department of Medicine Baylor College of Medicine Houston TX USA

4. The Institute for Clinical and Translational ResearchBaylor College of Medicine Houston TX USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3284

Reference75 articles.

1. Neoadjuvant therapy for breast cancer

2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

3. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

4. Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis

5. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring miRNA‑target gene profiles associated with drug resistance in patients with breast cancer receiving neoadjuvant chemotherapy;Oncology Letters;2024-02-16

2. Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial;Scientific Reports;2023-12-04

3. The Current Role of Neoadjuvant Chemotherapy in the Management of HER2-Positive, Triple-Negative, and Micropapillary Breast Cancer: A Narrative Review;Cureus;2023-11-30

4. Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer;Journal of Translational Medicine;2023-11-15

5. A Novel Albumin-Related Nutrition Biomarker Predicts Breast Cancer Prognosis in Neoadjuvant Chemotherapy: A Two-Center Cohort Study;Nutrients;2023-10-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3